WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gregory R. FribergEVP Chief RD Officer2026-05-073,281$53.85
$176.68kSell
George Eric DavisEVP Chief Legal Officer2026-03-181,273$56.05
$71.35kSell
Charles Greg GuyerEVP Chief Technical Officer2026-03-171,693$56.05
$94.89kSell
Brian MuellerEVP Chief Financial Officer2026-03-172,117$56.05
$118.66kSell
Cristin HubbardEVP Chief Commercial Officer2026-03-171,245$56.05
$69.78kSell
Alexander HardyChief Executive Officer2026-03-174,252$56.05
$238.32kSell
Gregory R. FribergEVP Chief RD Officer2026-03-171,629$56.05
$91.31kSell
George Eric DavisEVP Chief Legal Officer2026-03-167,177$58.51
$419.93kSell
Alexander HardyChief Executive Officer2026-03-132,941$58.51
$172.08kSell
Charles Greg GuyerEVP Chief Technical Officer2026-03-139,109$58.51
$532.97kSell

1 of 3

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Primecap Management Co7.34%14,194,005$755.69MInstitution
Vanguard Capital Management LLC4.47%8,643,164$460.16MInstitution
Vanguard Portfolio Management LLC4.29%8,298,475$441.81MInstitution
Dimensional Fund Advisors LP1.97%3,802,930$202.47MInstitution
Assenagon Asset Management Sa0.99%1,920,658$102.26MInstitution
Ubs Group Ag0.77%1,496,852$79.69MInstitution
Vanguard Fiduciary Trust Co0.62%1,194,118$63.57MInstitution
Pictet Asset Management Holding Sa0.62%1,193,661$63.55MInstitution
Bank Of New York Mellon Corp0.59%1,144,892$60.95MInstitution
Jean Jacques Bienaime0.50%962,817$51.26MInsider

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN31.66%1.78%Net SellingNet Selling
PRAX13.70%50.55%Net Selling
CYTK24.46%12.32%Net SellingNet Selling
ARWR24.25%9.77%Net SellingNet Selling
KRYS21.41%24.13%Net SellingNet Selling
View Top Biotech Stocks

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 31.66% institutional shareholders, 1.78% Biomarin Pharmaceutical insiders, and 66.56% retail investors. Jean Jacques Bienaime is the largest individual Biomarin Pharmaceutical shareholder, owning 962,817.00 shares representing 0.50% of the company. Jean Jacques Bienaime's Biomarin Pharmaceutical shares are currently valued at $49.88M.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.